The role of the renin-angiotensin system in aortic aneurysmal diseases. - Wikidata - awgldk - TriplyDB

The role of the renin-angiotensin system in aortic aneurysmal diseases.

The role of the renin-angiotensin system in aortic aneurysmal diseases.

http://www.wikidata.org/entity/Q33757332

about

Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease.Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms.Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways.A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.Complex pathologies of angiotensin II-induced abdominal aortic aneurysms Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm.Novel mechanisms of abdominal aortic aneurysms Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo.Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.SEX AND VASCULAR BIOMECHANICS: A HYPOTHESIS FOR THE MECHANISM UNDERLYING DIFFERENCES IN THE PREVALENCE OF ABDOMINAL AORTIC ANEURYSMS IN MEN AND WOMEN Pharmacological therapy for patients with abdominal aortic aneurysm.Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta.Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms.A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.Inhibitors of cathepsin G: a patent review (2005 to present).The pathophysiologic basis of abdominal aortic aneurysm progression: a critical appraisal.Pathophysiology of aortic aneurysm: insights from human genetics and mouse models.The relationship between vitamin D deficiency and coronary artery ectasia Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.Is there a role for biomarkers in thoracic aortic aneurysm disease?Treatment of thoracic aortic aneurysm.

P2860

Q33760484-F4FF1BC8-F9FA-4FC0-9C26-937681606091 Q33976385-25655CC2-7A1E-459D-97E9-9E76BBE297BC Q33999588-2AA1ECE4-24FD-4BFC-B0D4-03D745483C1E Q34044268-863378F5-BB74-40F6-9E83-3C6B0620CDF8 Q34382219-F71E771D-F9BA-4FE8-8021-989C19C35AD2 Q34506416-0F628881-D683-493D-A9C7-51B7288E0CC7 Q34507677-8DF9D5D1-C252-4547-8959-50F757377106 Q34560687-9AEC79A1-28D6-49A0-B63D-F915A09500F2 Q34562390-F6BE38F2-EEDA-4ACE-9B02-7A4E27B9BC6E Q34978499-27EBDA9C-92DC-44D7-A35C-39B2A651F4B1 Q35148843-526D85E8-168E-464C-800F-21F0A42DD202 Q35233864-0A4F9C77-8ADA-4737-8E7B-6AFDA7D3B404 Q36218494-9A766509-0EA9-4F6E-863A-11C281D72153 Q36457398-CF6A9B28-560B-4CC9-BB16-1A792C4573EB Q36573893-87D9BEA7-1B2B-420F-824F-8696E75F1D43 Q37086076-E2F62663-94B5-4FB8-AE04-024629D45B6D Q37349124-6EA68FA7-7E80-48BB-9FB7-4FD0D64C3D47 Q37366356-F9B37781-29DA-4D97-A20E-C594EA30E895 Q37452257-66AF0883-D1F9-4CC1-B419-32009CE20CB5 Q37558931-7DB0400A-781A-448A-8601-8AA35F28AA55 Q37563846-4B2E7530-0FD1-4EB9-8C8E-783A212382A4 Q37578569-7D9715A6-AB08-497B-B590-7155B84E6809 Q37670080-356EF93C-4EC5-4A35-BB52-F545530877EE Q38025669-E0F73B53-54A9-446C-83FD-16F101A31F5A Q38053510-5F9722AA-D214-4D5E-8318-F8F49A5450EA Q38147399-A8DF74EC-9E60-414D-9832-457DA098A730 Q38509684-0F515DA8-7200-4832-94E6-58A564E6D9CC Q39030430-EC2844B1-EA0B-4C3B-96E7-34C201AA23D2 Q41609159-5E446B9D-5B75-413B-9381-E5CBEF246716 Q46195806-476D4382-4487-48D5-89B1-080356219238 Q47871544-46A5CE51-7848-48C1-B87E-57E6156326EC Q52611415-FA98F676-DB7A-473B-814F-605EAF2730FA

P2860

The role of the renin-angiotensin system in aortic aneurysmal diseases.

http://www.wikidata.org/entity/Q33757332

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@ast

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@en

type

label

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@ast

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@en

prefLabel

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@ast

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@en

P1433

Q33757332-40B008EE-D1F5-4E40-853C-92B3BAF8B553

P1476

Q33757332-68C1C2BD-7244-46D3-90E5-99E63DCC6DBD

P2093

Q33757332-4679AE78-46C6-4730-9152-C97B20B4238D

Q33757332-4D644A3E-7F1D-425D-9F24-7F208AD9AC94

Q33757332-9B985644-F09D-4810-9C6E-C1C5AABFBF5B

Q33757332-A6BB99B5-6EDE-4490-860D-96F286D014C6

P2860

Q33757332-1CD80E3D-A0CC-4F73-BCF9-295834D5B785

Q33757332-20E1E91B-56A7-4175-A01F-043E74A4E99E

Q33757332-20EDF517-2482-4D1E-8A45-832F01193269

Q33757332-2B677858-5569-4058-B813-14324B3CDA5B

Q33757332-2BB004D1-1E3F-4CB7-9326-2B363CA127C3

Q33757332-2BB3515D-84F1-40BE-A4B4-2D7933B200FF

Q33757332-3028F251-92FE-4172-B80A-2B4C7C34E4F9

Q33757332-4C352E4E-59BA-4965-BAC7-F42E673DB466

Q33757332-56FF817A-0CB4-4410-9CB0-D86FC4510B74

Q33757332-57586B7E-1925-4A95-8DF0-DB96C7B56628

P2888

Q33757332-BA0CAD39-DB1C-484D-B49D-42378CB259AA

P304

Q33757332-F592814C-0301-44C4-AC65-F1E20FC78D15

P31

Q33757332-6EDF1F42-A510-4187-A787-797C958394B0

P356

Q33757332-F8C8FBBF-CFCE-4656-8BDF-309A463ADFA5

P433

Q33757332-D851A384-584A-405D-8401-21DA04BAE403

P478

Q33757332-A5E54217-63CB-4296-850E-83FB83C03329

P577

Q33757332-E72320D5-F04A-4E9C-AA82-6054FE8EE18B

P5875

Q33757332-25923412-87A1-4CB2-82C3-89E764A76E7B

P6179

Q33757332-04AA8207-EDEB-4CDF-A35A-AB36C38BB08B

P698

Q33757332-EAF34812-FC29-4935-95FA-EE81D108734A

P921

Q33757332-F0269981-A35D-4E7A-87F2-98E5D25C2B98

P932

Q33757332-52CC0D53-0A6B-4A3D-B7A0-84BB3AB5C69D

P356

S11906-008-0020-3

P1433

Current Hypertension Reports

P1476

The role of the renin-angiotensin system in aortic aneurysmal diseases.

@en

P2093

Alan Daugherty

http://www.w3.org/2001/XMLSchema#string

Debra L Rateri

http://www.w3.org/2001/XMLSchema#string

Hong Lu

http://www.w3.org/2001/XMLSchema#string

Lisa A Cassis

http://www.w3.org/2001/XMLSchema#string

P2860

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.

MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

Abdominal aortic aneurysm: pathogenesis and implications for management.

Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease.

P2888

s11906-008-0020-3

P304

99-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-008-0020-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5377773

http://www.w3.org/2001/XMLSchema#string

P6179

1028174290

http://www.w3.org/2001/XMLSchema#string

P698

18474175

http://www.w3.org/2001/XMLSchema#string

P921

P932

2846534

http://www.w3.org/2001/XMLSchema#string